Commentary in 2018

Filter By:

Article Type
Year

  • The Open Material Transfer Agreement is a material-transfer agreement that enables broader sharing and use of biological materials by biotechnology practitioners working within the practical realities of technology transfer.

    • Linda Kahl
    • Jennifer Molloy
    • Drew Endy
    CommentaryOpen Access

  • Greater safeguards are needed to address the personal safety, security and privacy risks arising from increasing adoption of neurotechnology in the consumer realm.

    • Marcello Ienca
    • Pim Haselager
    • Ezekiel J Emanuel
    Commentary

  • Expert curation at present remains the only reliable solution for interpretation of mutation information in the clinical practice of oncology.

    • Kathryn D Bungartz
    • Kristen Lalowski
    • Sheryl K Elkin
    Commentary

  • Why digitally powered real-world evidence is the fix needed for our broken clinical trials system.

    • Vicki Seyfert-Margolis
    Commentary